ELIXIR MD™ Secures First and Only FDA Clearance For Soft Tissue Coagulation For LED Light Therapy in Plastic Surgery
The FDA clearance is a significant achievement for ELIXIR MD™ and a testament to the safety and effectiveness of its EPBM™ technology. This clearance allows plastic surgeons to use ELIXIR MD™ device in a variety of procedures. The EPBM™ technology utilizes specific wavelengths of light to stimulate cellular activity, promoting healing and reducing inflammation, pain, and scarring.
"ELIXIR MD™ is committed to investing in R&D to provide plastic surgeons with the advancements they need to deliver the highest quality of care and achieve the fastest post-surgery results," said Ewan Yassen, CEO of ELIXIR MD™. "The new indication for soft tissue coagulation for LED light therapy in plastic surgery enhances the product's intended use, helping practitioners expand their patient base."
Since its inception, ELIXIR MD™ has been gaining widespread global brand awareness, with more than 70 plastic surgeons using the system worldwide. The ELIXIR MD™ brand is poised to become the new standard in plastic surgery for post-op recovery solutions.
About ELIXIR MD™
ELIXIR MD™ is at the forefront of medical innovation, dedicated to enhancing well-being and delivering impressive results. Specializing in Photobiomodulation Devices, our unique EPBM™ technology is designed to support Plastic Surgeons in enhancing surgical procedures and reducing recovery times. Our cutting-edge technology positions us strongly in the multi-billion dollar market, spanning various surgical specialties including plastic surgery and ENT. For more information about ELIXIR MD™ and its technology, visit www.elixir-md.com.
Michael Elias
ELIXIR MD™
+1 949-695-7727
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube
Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, Media, Advertising & PR, Technology
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release